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1. Introduction    
Neurochemical pathways involved in brain physiology or disease pathogenesis are mostly 
unknown either in physiological conditions or in neurodegenerative diseases. Nowadays 
the most frequent usage for biotelemetry is in medicine, in cardiac care units or step-down 
units in hospitals, even if virtually any physiological signal could be transmitted (FCC, 2000; 
Leuher, 1983; Zhou et al., 2002). In this chapter we present a wireless device connected with 
microsensors and biosensors capable to detect real-time variations in concentrations of 
important compounds present in central nervous system (CNS) and implicated in brain 
energetic metabolism (Bazzu et al., 2009; Calia et al., 2009).  
Molecular Oxygen (O2), an essential molecule for life, is utilized not only for cellular 
respiration but also for biosynthesis and metabolism of various important biomolecules 
such steroids, eicosanoids and neuroactive substances (Watanabe et al., 1997). It is also 
implicated in several biochemical reactions involving, for instance, ATP in the brain (Bazzu 
et al., 2009). To monitor istantaneous oxygen concentrations and relative variations could 
give important information about brain energetic metabolism related to glucose (Fillenz, 
2005) or lactate consumption (Aubert et al., 2005). Eletrochemical reduction of oxygen is 
amperometrically obtained by means of complex transformations occurring at a carbon-
epoxy sensor surface by applying a potential of -400 mV vs Ag/AgCl reference electrode 
(RE) (Bazzu et al., 2009; Calia et al., 2009) as follows: 
 O2 + 2H+ + 2e- → H2O2  (1) 
 H2O2 + 2H+ + 2e- →  2H2O  (2) 
Because of its anatomical characteristics and physiology, the central nervous system (CNS) 
is assumed to be particularly sensitive to oxidative stress (Emerit et al., 2005). Oxidative 
stress in CNS is now known as responsible for involvement of reactive oxygen species (ROS) 
and reactive nitrogen species (RNS). This particular kind of stress is crucial for the 
modulation of fundamental cellular functions as apoptosis, calcium mobilization, ion 
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transport and all phenomena involved in excitotoxicity (Emerit & Edeas, 2005). Oxidative 
stress takes place from a disparity, involving the physiological antioxidant capability and 
free radicals synthesis (Andersen, 2004), so the dynamics concerning antioxidants in CNS 
are extremely important. 
Ascorbic acid (AA) is the most important component of antioxidant pool in the brain (Serra 
et al., 2002). Low molecular weight antioxidant AA is a water soluble vitamin that owns 
radical scavenger properties against ROS and RNS (Serra et al., 2002). As it is not produced 
in human organism but introduced with diet (Hediger, 2002), the presence of a specific 
transporter (SVCT2) allows its cytosolic internalization in neurons. Ascorbic acid is readily 
oxidized to dehydroascorbate (DHAA) which can undergo irreversible hydrolysis to 2,3-
diketo-L-gulonic acid, but because of its crucial role in CNS, DHAA is easily converted to 
the reduced form for preventing vitamin C depletion. AA is as well implicated in the 
protection against excitotoxicity due to high glutamate concentration through ascorbate-
glutamate hetero-exchange (Rice, 2000). Ascorbic acid is readily oxidized on epoxy-carbon 
electrode surface at + 120 mV against Ag/AgCl as follows: 
 L-Ascorbic acid (+120 mV) → DHAA + 2e- + 2H+  (3) 
Several biologically interesting compounds are not directely oxidizable at a sensor surface, 
in this case it is needed a biosensor (Pantano et al., 1995). Biosensor combines a trasducer 
with an enzyme that is capable to give sensitivity and selectivity to the device (Scheller et al., 
1997). 
Glucose (GLU) is actively involved in ATP synthesis and its concentration in extracellular 
spaces is the most important factor for energetic metabolism (Lowry et al., 1998; Magistretti 
et al., 1999, Fillenz et al., 2005). GLU detection is possible by means of loading on a Pt 
surface transducer glucose oxidase (GOx) enzyme. GOx is covalently linked with flavin 
adenine dinucleotide (FAD) (Serra et al., 2007) and is extremely reliable because of its good 
sensitivity to the enzyme substrate and high stability when immobilized on Pt electrodes by 
means of poly-orthophenylenediamine (OPD) (Wilson et al., 1992; Lowry et al., 1998). The 
biosensor-based detection of GLU occurs as follows: 
 β-D-Glucose + FAD+-GOx → D-Glucono-δ-Lactone + FADH2-GOx  (4) 
 FADH2- GOx + O2→FAD+-GOx + H2O2  (5) 
As glucose, lactate (LAC) is an important molecule involved in brain energetic metabolism 
as product of glicolysys (Fillenz, 2005) or energetic substrate for neurons (Magistretti et al., 
1999). LAC is oxidized by lactate oxidase (LOx), an enzyme with a covalently-linked FAD 
cofactor (Serra et al., 2007). After the oxidation of the substrate, the further oxidation of 
FADH2 to FAD+ produces H2O2 in the presence of O2.  
 L-Lactate + FAD+-LOx → Pyruvate + FADH2-LOx  (6) 
 FADH2- LOx + O2→FAD+-LOx + H2O2  (7) 
The application of a positive potential (+700 mV vs Ag/AgCl) to a Pt working electrode 
generates a current proportional to the concentration of the H2O2. Reactions occur as 
follows: 
 H2O2 → O2 + 2e- + 2H+  (8) 
www.intechopen.com
Design and Construction of a Distributed Sensor NET for Biotelemetric Monitoring  
of Brain Energetic Metabolism using Microsensors and Biosensors  
 
243 
where the amount of current produced by the previous oxidation (8) is proportional to the 
quantity of substrate (GLU or LAC) transformed by the enzyme. The intrinsic chemical 
characteristics of each indicated molecule allow using specific telemetric devices able to 
work in oxidation mode (Calia et al., 2009) or in reduction mode (Bazzu et al., 2009; Calia et 
al., 2009). In this chapter we describe the implementation of a distributed biosensor NET, 
composed by implantable biotelemetry devices and derived from previously published 
systems (Bazzu et al., 2009; Calia et al., 2009), successfully used in conjunction with micro-
biosensors for the in-vivo measurement of brain O2, AA, glucose and lactate. The analysis of 
signals derived from the above sensors allowed the real-time study of biochemical pathways 
involved in brain energetic metabolism. The design, construction and operation of the 
hardware, firmware and software are described. The proposed system, based on simple and 
inexpensive components, could be used as a rapid and reliable model for the real-time study 
of the effects of different drugs on brain neurochemicals and offers the possibility of 
expanding the biotelemetric NET simply and quickly. 
2. Biotelemetric system hardware    
The electronic circuit of the implantable biotelemetric device (Fig. 1) was built using surface 
mount components and comprised two different parts: the amperometric module and the 
microcontroller/transceiver module.  
 
 
Fig. 1. Pictures showing the biotelemetry system developed during this study (see text).  
As schematized in figures 2 and 3, the amperometric module was made soldering a quad 
operational amplifier (MCP6042), a Zener diode (ZXRE4001), two resistors, a 
potentiomenter and one capacitor on a 28 mm x 17 mm PCB. The MCP6042 can operate 
from a single-supply voltage with “rail-to-rail” inputs and outputs; it has been designed for 
micropower applications consuming only 600 nA per OPA with low input bias current (1 
pA) and high input resistance (>1013Ω).  
The zener diode plays a pivotal role in the amperometric circuitry; as bandgap voltage 
reference, it generates a fixed voltage (Vz = 1.22 V) consuming around 10 µA in virtue of a 
limiting resistance (150K).  
The not inverting input of the potentiostat was connected to Vz (Bazzu et al., 2009; Calia et 
al., 2009) for working with O2 microsensors (reduction mode, Fig. 2).  
In oxidation mode (Fig. 3), the above mentioned input of the potentiostat was grounded 
resulting in a positive potential applied to working electrode (WE) ranging from ground 
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Fig. 2. Schematic of the amperometric module of the biotelemetric device working in 
“reduction mode”.  
(GND) to Vz. The inverting input of the potenziostat was directly connected to RE while its 
output wired to the auxiliary (AE) electrode. This allows the implementation of a feedback 
circuit in which RE and AE potentials are maintained at the same potential of the not-
inverting input (potentiostatic circuit). 
The buffered voltage divider, composed by the potentiomenter and the voltage follower, 
generated the potential necessary to polarize the WE in a range comprised between 0 and 
1.22 V (Vz, controlled by ZXRE4001).  
 
 
Fig. 3. Schematic of the amperometric module of the biotelemetric device working in 
“oxidation mode”.  
The current-to-voltage (I/V) converter is a single-supply adaptation of a classic 
transimpedance amplifier and derived form a previously-published design (Serra et al., 
2007; Rocchitta et al., 2007). The transfer function of the I/V converter is: 
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 VOut = -(Iredox · R) + VApp  (9) 
in which  Iredox is the current flowing through the WE, R is the feedback resistor and VApp is 
the potential applied to the WE (versus ground). For example, working in reduction mode, a 
current of 0 nA corresponds to VApp (0.8 V, -0.4 V vs Vz) while with a cathodic current of -30 
nA VOut is equal to 0.5 V (R=10MΩ).  The maximum allowable current is ≈ -80 nA (VOut = 0.0 
V). Instead, when the system is configured in oxidation mode, a maximum anodic current of 
18 nA can be read without saturation (VApp = 0.7 V; VOut = 2.5 V; R =100MΩ). The feedback 
resistor (R) has a capacitor in parallel (C) to complete a low-pass filter with a cut-off 
frequency (Fcut-off) of 5 Hz. The value of C was calculated in Farads according to the 
equation: 
 C = 1 / (Fcut-off  2π  R)  (10) 
A dummy cell was made based on a previously published design (Serra et al., 2007) for 
testing the amperometric module of the biotelemetric device before sensors calibration. The 
aim of the design was to devise a Thevenin current source that would reproduce the 
constant amperometric response of a true electrochemical cell. The voltage applied to the 
dummy cell was generated between the WE and RE/AE and is equal to the voltage 
difference between the above electrodes. The resulting currents were converted in an output 
voltage (VOut) as illustrated above. Data obtained from electronics calibration are similar to 
those obtained in previous studies (Bazzu et al., 2009; Calia et al., 2009). 
The MSP430F2274 (Texas Instruments, TI) is the heart of the digital module. This is a 16-bit 
CMOS IC with ultra-low power features equipped with internal 10 bit ADCs. The 
microcontroller unit (MCU) performed the A/D conversion of VOut, VBatt, VApp and in-chip 
temperature using a 2.5 V internal reference. After the digital signal processing (DSP) of 
acquired raw data, a serial data packet was generated and sent to the transceiver: the TI 
CC2500 multi-channel RF transceiver, designed for low-power wireless applications (2.4 
GHz).  
Several pins of the microcontroller were connected to the CC2500 providing the data lines of 
the transceiver. In conjunction with the MCU, this component allows the realization of a 
serial data transmitter working at the speed of 9600 baud. A miniaturized chip antenna was 
integrated in the PCB board. The in-circuit-serial-programming (ICSP) bus provides the 
possibility of programming the MCU “on-board” in a few seconds. The digital module (Fig 
1B; Fig. 1C) is commercially available pre-assembled by TI (eZ430-RF2500). A 210 mAh, 3 V 
lithium coin battery (Maxell CR2032) provided the power to the biotelemetric device for up 
to one week in continuous transmission (1 Hz). A small plastic enclosure (3.2 x 2.1 x 1.4 mm; 
Fig. 1A) completed the implantable device (Fig. 1B, inset). The weight of the implantable 
device (Fig.1, inset) is 12.4 grams including battery. A second digital module (wired unit, 
Fig. 1C), connected to a personal computer (PC) by means of an USB-programmer, coupled 
the implanted biotelemetric device with the software running on the PC side (Fig. 4). 
3. Firmware and software   
The firmware to drive the MSP430F2274 MCUs was realized in C language using IAR 
Embedded Workbench (version 5.20, KickStart) freely available from www.ti.com. The 
program, which runs on the biotelemetry device, consists of two routines: the main 
procedure and a timer-interrupt routine called every second as illustrated in Figure 5. 
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Fig. 4. Schematic of the biotelemetric system developed and used in this study. 
 
Fig. 5. Firmware running on the implantable biotelemetric device. 
When the analogue signal VOut was digitized, the hardware ADC resolution (10 bit) was 
improved following the oversampling and averaging method (Pagnacco et al., 1997): 
 Fos = 4w · Fs  (11) 
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where w is the number of additional bits of resolution (2), Fs is the sampling frequency (1 
Hz) and Fos is the oversampling frequency. In accordance with the Nyquist’s theorem Fs was 
calculated as follows: 
 Fs = 2 ·  Fmax  (12) 
in which Fmax has been fixed to 2 Hz. To do that, the MCU acquired and accumulated 64 
consecutive samples then divided the result by 26 (Fig. 5). This technique increased the ADC 
resolution from 10 to 12 bits. The RF data packets (1 per second), sent by the MCU, were 
encapsulated in an Open Source Stack (SimpliciTI™), implemented by Texas Instruments 
for the development of low power wireless NETs. Up to 100 implantable units, with an 8 bit 
ID memorized in their E2PROM, can share the same transmission channel. The interrupt-
driven routine on the receiver unit, mounting a second MSP430F2274, communicates to the 
PC using USB and filters the IN-OUT data. The firmware was downloaded to the MCUs 
using the TI USB programmer connected to the ICSP bus (Fig. 6). 
 
 
Fig. 6. Program process of MSP430F2274 consisting on edit-compile-download cycle. 
The software, running on the PC under Windows XP Professional™ or Vista™, 
communicates thought the USB by using the low-level driver freely available from 
www.ti.com. The graphic user interface (Fig. 7) was developed using Profilab Expert® 
(version 4.0 from Abacom) while the dynamic link library (DLL) serial-data-parser was 
programmed in C (Dev-C++ ver. 4.9.9.2).  
The application (capable of plotting, storing and retrieving data) interfaces the system with 
a printer via USB and a Local Area Network (LAN) and Internet via TCP/IP (Fig. 4). A 
software alarm was generated if VBatt< 2.7 V, signal strength (RSSI) too low or a data 
reception time-out occurred. 
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Fig. 7. Simple graphic user interface of the data-acquisition software running on the PC. 
4. Statistical analysis    
Concentrations of O2 were expressed in µM while AA, glucose and lactate in mM. Oxygen, 
ascorbate and H2O2 signals were expressed in nA and given as baseline-subtracted data 
(ΔnA). The sensors in-vitro response was characterized immediately before implantation and 
the electrochemical parameters evaluated before in-vivo experiments. The changes of brain 
tissue neurochemicals were calculated as absolute variations versus the corresponding 
baselines and their striatal concentrations were estimated using pre-implantation in-vitro 
calibrations.  
Statistical significance of changes was evaluated using paired t-tests between the means of 
300 consecutive recordings before (baseline) and during the maximum magnitude of 
neurochemical changes as a result of physiological stimulation (tail pinch).  
Pearson's correlation coefficient was used to show correlation significance of current 
variations induced by tail pinches among O2, AA, glucose and lactate. Immediately after the 
stimulus application, the first five minutes of raw data (n=300) were compared point-by-
point. The null hypothesis was rejected when p < 0.05. 
5. Design, construction and calibration of oxygen and ascorbic acid 
microsensors 
Oxygen microsensor construction and calibration were performed as previously described 
(Bazzu et al., 2009; Calia et al., 2009). Briefly, 1 mm silver wire (25 mm in length; Ø=125 µm, 
Advent Research Materials, Suffolk, UK) was introduced in a silica capillary tube (10 mm in 
length; I.D. Ø=180 µm, Polymicro Technologies, Phoenix, USA), partially filled with epoxy-
carbon (EC) obtained mixing 450 mg of graphite with 350 mg epoxy resin (Araldite-M®, 
Sigma-Aldrich, Milan, Italy). A 180 µm diameter carbon composite disc electrode was made 
up and left 12 hours at 60°C. A conical shape was provided to the microsensor by drilling 
the tip. 
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The final oxygen microsensors (Fig. 8) had a length about 250 µm, a surface of 0.00145 cm2 
and a tip < 25 µm. Nitrocellulose (NC, collodion) treatment was carried out dipping the 
microsensor in the collodion solution (4% nitrocellulose in ethanol/diethyl ether) 3 times 
and drying it for 1 hour at 40 °C after each coating. Cellulose nitrate membrane, because of 
its hydrophobic properties, sets a barrier for large organic molecules, as proteins, avoiding 
poisoning of microsensor surface while can be crossed by small charged ions and gases 
(Bazzu et al., 2009). 
 
 
Fig. 8. Schematic representation of the oxygen microsensor used in this study.  
O2 reduction potential was experimentally determined in a previous study (Bazzu et al., 
2009) using cyclic voltammetry and fixed at at -400 mV vs Ag/AgCl reference electrode. 
Constant potential amperometry (CPA) was used for in-vitro and in-vivo calibrations and 
experiments. No significant interferences were remarked on exposing sensors to other 
electroactive molecules (AA, UA, DA, DOPAC and HVA) present in the striatal extracellular 
fluid at pharmacologically significant concentrations (Calia et al., 2009). O2 microsensor was 
calibrated by adding known volumes of a standard O2 solution (100%) to nitrogenated PBS 
and only sensors with sensitivity lower than 10 µM were chosen. All in-vitro calibrations of 
oxygen microsensors were carried out 24 h after manufacture, immediately before 
implantation, using a previously-described electrochemical cell (Serra et al., 2007; Rocchitta 
et al., 2007) appropriately set for oxygen (Bazzu et al., 2009). The calibration (Fig. 9) 
exhibited good linearity showing a slope of -254 ± 32 pA µM-1 of O2 (R2=0.999; n=6), in line 
with previous observations (Calia et al., 2009). 
AA microsensors (Fig. 10) were manufactured in the same way as oxygen microsensors 
without the collodion layer or any further surface modification. 
In-vitro calibrations of ascorbic acid microsensors were carried out in fresh PBS at room 
temperature (25 °C) before implantation. A constant potential of +120 mV was applied and 
after a stabile baseline was reached, known amount of ascorbic acid stock solution were 
added to PBS in order to obtain concentrations ranging from 0 to 5 mM.  
AA microsensors, calibrated before implantation (Fig. 11), showed good sensitivity and 
good linearity (2.96 nA ± 0.1 mM-1, R2= 0.998, n=6). 
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Fig. 9. Oxygen microsensor in-vitro calibration.  
 
Fig. 10. Schematic representation of the ascorbic acid microsensor used in this study. 
 
Fig. 11. Ascorbic acid microsensor in-vitro calibration.  
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6. Design, construction and calibration of glucose and lactate biosensors  
The design of the glucose biosensors (Fig. 12) has been previously described in detail (Serra 
et al., 2007). Briefly, 1 mm platinum (Pt) cylinder, obtained cutting Teflon-insulated Pt wire 
(Ø=125 µm, Advent Research Materials, Suffolk, UK), was immersed for 5 min into a 
solution of glucose oxidase (GOx) to allow adsorption. After 10 min drying at room 
temperature, the biosensor was placed in the cell filled with 5 ml of nitrogenated PBS 
containing the o-phenylenediamine monomer (OPD, 250 mM). The electrosynthesis of poly-
o-phenylenediamine (p-OPD) was carried out at +700 mV vs Ag/AgCl reference electrode 
for 15 min. After electropolymerization, the biosensor was stored in fridge (4°C).  
 
 
Fig. 12. Schematic representation of the glucose biosensor used in this study.  
The in-vitro calibration of glucose biosensor was made in air-bubbled PBS performing ten 
successive injections of glucose (0.2, 0.4, 0.6, 1, 2, 10, 20, 60, 100, 140 mM). The calibration 
data (Fig. 13) well fitted with the Michaelis-Menten equation (R2=0.984, n=6) with a VMAX of 
59.6±0.8 nA and a KM of 5.6±0.4 mM. The response to low concentration of glucose (0-2 mM; 
Fig. 13, inset), revealed excellent linearity (R2=0.999, n=6) and a slope of 8.9±0.08 nA mM-1. 
 
 
Fig. 13. In-vitro calibration of glucose biosensor (see text). 
The fabrication of the lactate biosensors (Fig.14) has been derived from a previously 
described procedure used to make glutamate biosensors (McMahon et al., 2006). A Pt 
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cylinder (1 mm) was placed in the electrochemical cell containing nitrogenated PBS and 
OPD monomer and p-OPD was electrosynthesized as previously described for glucose 
biosensor. The Pt/p-OPD cylinder was immersed (quick dip) into a solution of 
polyethylenimmine (PEI, 0.5%in water)-LOx (25 U/50 µl of PBS) to allow oxydase 
adsorption. After 5 min drying at room temperature, the dipping procedure was repeated 
four times.  
With the purpose of increasing the KM of the biosensor, a diffusion-reducing membrane 
(Schuvailo et al., 2006) was applied on top of the PEI-LOx layers by dipping the biosensor in 
a polyurethane (PU) solution (2.5% in tetrahydrofurane). Finally, the biosensor was stored in 
fridge.  
Constant potential amperometry (CPA) was used for in-vitro and in-vivo experiments fixing 
the H2O2 oxidation potential at +700 mV (Serra et al., 2007) vs Ag/AgCl.. All in-vitro 
calibrations were performed in fresh PBS 24 h from sensors’ manufacture as previously 
described in detail (Rocchitta et al., 2007).  
 
 
Fig. 14. Schematic representation of the lactate biosensor used in this study.  
The in-vitro response of lactate biosensor was determined only before implantation adding 
known amounts of lactate in the electrochemical cell giving concentrations ranging between 
0 and 150 mM.  
Calibrations showed a classical Michaelis-Menten kinetic (R2=0.944, n=6) with VMAX and KM 
equal respectively to 92.8±2 nA and 8.7±0.9 mM (Fig. 15). Linear region was evaluated at 
low concentration (0-5 mM) and it showed good linearity (R2=0.997, n=6) with a slope of 
6.7±0.2 nA mM-1 (Fig. 15, inset). 
No significant interference signals were observed on exposing biosensors to AA or other 
electroactive molecules present in the striatal extracellular fluid, even at pharmacologically 
relevant concentrations (Calia et al., 2009).  
7. Animals and neurosurgery 
Male Wistar rats (Morini R. Emilia, Italy), weighing 250-350 g were used in all experiments. 
Rats were kept under standard animal care conditions with 12 h light/dark cycle, and room 
temperature 21°C, food and water ad libitum. 
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Fig. 15. In-vitro calibration of lactate biosensor (see text). 
All procedures were licensed under the European Community directive 86/609 included in 
Decreto No. 116/1992 of the Italian Ministry of Public Health.  
Stereotaxic surgery was performed under chloral hydrate (400 mg Kg-1 i.p.) anesthesia and 
body temperature during anaesthesia was maintained at 37 °C by means of an isothermal 
heating pad. 
Before each experiment, the health of the animals was assessed according to published 
guidelines (Wolfensohn and Lloyd, 2003). 
O2 and AA microsensors, glucose and lactate biosensors were implanted in the right 
striatum (Fig. 16) using the following coordinates from the atlas of Paxinos & Watson 
(Paxinos & Watson, 2007): A/P +0.5 from bregma, +2.5 M/L, and -4.0 D/V from dura. 
Reference and Auxiliary electrodes were implanted in the parietal cortex. 
 
 
Fig. 16. Amperometric sensor inserted in the right striatum by means of sterotaxic surgery. 
The sensor was wired to the biotelemetric device fixed to the skull (inset).  
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The biotelemetric device was fixed by mean of two screws inserted in the skull (Fig. 16, 
inset), as previously described (Bazzu et al., 2009; Calia et al., 2009).  
Following surgery, the animals were housed in large Plexiglas bowls (45 cm diameter), and 
maintained in a temperature- and light- controlled environment, with free access to food 
and water. The sensors were connected 24 h after surgery. The monitoring of 
neurochemicals started with the animal in its home bowl allowing the rat free movement 
(Fig. 17).  
 
 
Fig. 17. Biotelemetric device implanted in a freely-moving rat.  
8. In-vivo experiments and results  
Baseline recordings and physiological stimulation were carried out within the first day after 
stereotaxic surgery, starting 24 h after implantation. The Oxygen microsensor reached a 
stable baseline (-24.3 ± 2.7 nA) after a period of about 50 minutes from the application of the 
working potential. Considering that the background current of the microsensor in nitrogen-
saturated PBS was -14.2 ± 0.9 nA, it is possible to estimate the concentration of O2 using in-
vitro pre-calibration; this was found to correspond to 39.8 ± 7.1 μM, a value in agreement 
with previous results (Bazzu et al., 2009; Calia et al., 2009). Physiological stimulation as five-
minute tail pinch (Fig. 18), administered in order to increase neural activity and to promote 
regional cerebral blood flow (rCBF), led to an increased motor activity yielding to a striatal 
O2 current of -2.97 nA, corresponding to +11.69 µM, statistically different from baseline 
(p<0.001; Fig. 18, inset). 
Striatal oxygen dynamics, following physiological stimulation, resulted in a rise in the local 
O2 signal, mainly related to an increase of rCBF during neural activation in agreement with 
previous findings (Bazzu et al., 2009; Calia et al., 2009).  
A stable AA baseline was reached after a period of about 25 minutes. The calculated AA 
baseline corresponded to a concentration of 566 µM, in line with previous findings (Calia et 
al., 2009).  A physiological increase (p<0.001; Fig. 19, inset) of striatal AA current (+0.447 nA 
corresponding to +228 µM) was observed immediately after the administration of a 5 min 
tail pinch (Fig. 19). 
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Fig. 18. Effect of physiological stimulation (5 min. tail pinch, vertical band) on striatal 
dissolved oxygen.  
  
Fig. 19. Effect of a 5 min. tail pinch (vertical band) on striatal AA. 
This result is consistent with the activation of the AA/glutamate heteroexchange system 
(Rice, 2000) in which AA release is related to glutamate release and uptake subsequent to 
neural activation (Miele et al., 2000). 
Glucose biosensor in-vivo experiments were carried out using the same procedures as 
oxygen and AA ones. Thirty minutes after biosensor activation a stable anodic current 
corresponding to 4.6±0.24 nA (517±26 µM from in-vitro calibration) was reached. 
Physiological stimulation (Fig. 20) produced a significant decrease of glucose signal (-167 
µM; Fig. 20, inset) followed by its increase after stimulus suspension. 
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Fig. 20. Effect of a 5 min. tail pinch (vertical band) on striatal glucose. 
A stable baseline was observed 40 min after lactate biosensor polarization and corresponded 
to 5.09±0.43 nA (759±62 µM from the above in-vitro calibration). A five-minute tail pinch 
(Fig. 21) resulted in a significant increase of lactate signal during stimulus administration 
and after stimulus suspension (+544 µM, p<0.001; Fig. 21, inset).  
 
 
Fig. 21. Effect of a 5 min. tail pinch (vertical band) on striatal lactate. 
These results are suggestive of glucose consumption and lactate production during neural 
activation followed by an increase of extracellular levels of glucose subsequent to astroglial 
glycogenolysis (Fillenz et al., 1999). Figure 22 shows Pearson's correlation analysis of current 
variations induced by tail pinches among O2, AA, glucose and lactate. 
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Fig. 22. Pearson's correlation analysis of striatal neurochemical changes during neural 
activation. 
It is important to remember that an increase in anodic currents (AA, glucose and lactate) 
reflects a striatal increase of the above neurochemicals while an increase in extracellular 
dissolved O2 levels, corresponds to an increase in cathodic oxygen current, resulting in a 
more negative signal. Results of correlation analysis are summarized in Table 1. 
 
 Ascorbic Acid Glucose Lactate 
Oxygen r = -0.819 
P<0.0001 
r = 0.401 
P<0.0001 
r = -0.457 
P<0.0001 
Ascorbic Acid  r = -0.266 
P<0.0001 
r = 0.518 
P<0.0001 
Glucose   r = -0.388 
P<0.0001 
Table 1. Results of correlation analysys of striatal neurochemical changes during neural 
activation. 
After each experiment, rats were sacrificed with an injection of chloral hydrate (800 mg Kg-1 
i.p.). The location of each sensor was established by post-mortem histology. Brains were 
fixed in formal saline and 50 µm coronal sections were made with a cryostat. The slices were 
stained with cresyl violet and examined under a microscope.  
9. Discussion and conclusion 
In this chapter we have described the development of a distributed sensor NET for 
biotelemetric monitoring of brain neurochemistry using amperometric microsensors and 
biosensors. The implantable biotelemetric units, based on simple and inexpensive 
components, have been successfully used for accurate transduction of the electrochemical 
signals generated on the surface of the sensors implanted in the striatum of freely-moving 
rats. At this stage of development the system exhibits high stability and excellent linear 
response in the nanoampere current range. The choice of low-power CMOS technology 
makes the project suitable of further improvements such as the reduction of the power 
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consumption. The use of surface mount components and careful PCB design will make it 
possible to further miniaturize the circuitry. As result of in-vivo experiments, we have 
shown some preliminary data obtained monitoring important brain molecules during short-
time neural activation (5’ tail pinch). The study was carried out using new microsensors, 
biosensors and the newly-developed biotelemetric device in order to record real-time 
changes of key neurochemical markers of brain bioenergetic metabolism. Indeed, all studied 
species (oxygen, AA, glucose and lactate) are implicated in brain energetics.  
Recently, Castro and coworkers (Castro et al., 2009) proposed a new pivotal role for AA as 
modulator in the metabolic switch between glucose and lactate as energetic substrate of 
neurons. This review paper, mainly based on in-vitro results, summarizes the evidences of 
the relationships among glutamate, AA, glucose and lactate during neural activation. In 
figure 23, we repropose the model suggested by Castro, updated on the basis of our in-vivo 
results. In brief, in normal conditions both neurons and astrocytes use glucose as energetic 
substrate. After neural activation, cortico-striatal endings release glutamate (1) in the striatal 
extracellular compartment (Miele et al., 2000). Immediately after, GLU is taken by astrocytes 
from the synaptic cleft and exchanged (Rice, 2000) with AA (2).  The in-vivo increase of 
extracellular AA during tail pinch is in accord with this mechanism. The glutamate entry 
into astrocyte stimulates glucose internalization (3), glycolysis (4) and lactate efflux (5). We 
observed a reduction of extracellular glucose and an increase of lactate during tail pinch in 
agreement with this model. Finally, ascorbic acid enters neurons (6) through a specific 
transporter (SVCT2) and activates the metabolic switch (Castro et al., 2009), stimulating lactate 
uptake in neurons (7) and inhibiting glucose consumption (8). The rise in the local O2 signal, 
 
 
Fig. 23. Neurochemical pathway involved in brain energetic metabolism during neural 
activation. Glut: glutamate; Gluc: glucose; Lac: lactate; Pyr: pyruvate; GLUT: glucose 
transporter; SVCT: AA transporter; MCT: lactate transporter. 
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during neural activation, might reflect an increase of rCBF (Bazzu et al., 2009; Calia et al., 
2009). Immediately after the end of the physiological stimulation, AA current inverted its 
trend and slowly (10 min) returned to baseline levels. Oxygen and lactate currents 
continued to rise for 5 min after the end of the tail pinch then slowly decreased to baseline 
levels. The drop of glucose during neural activation was followed by its increase as result of 
astroglial glycogenolysis (Fillenz et al., 1999). Post-activation data are complex to interpret 
and suggest the return to normal (inactive) condition with glucose as energetic substrate for 
neurons. It is important to remember that AA is oxidized to DHAA by ROS and RNS in 
neurons (Serra et al., 2002). DHAA, secreted in the extracellular space, enters astrocyte 
through GLUT1 transporter and is back-reduced to AA (Hediger, 2002). A sustained 
increase of extracellular glucose could interfere with AA/DHAA cycle resulting in oxidative 
stress, AA loss and neuron damage. 
These in-vivo results indicate that, during neural activation in physiological conditions, 
extracellular striatal changes of the above neurochemicals mainly reflect astrocyte response 
to glutamatergic stimulation. Further in-vivo pharmacological studies are necessary to 
confirm in-vitro evidences on bioenergetic substrates used by neurons in different 
experimental conditions. 
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